14 days with a glucose sensor: your diet, with real data
A sensor does not measure blood sugar, it measures glucose in your tissue. What it can still show you, and what a test plan looks like that ends in more than a pretty curve.
More guides from the nutrition cluster
A glucose sensor does not answer a question. It asks one. And yet for many people the small device on the arm becomes a fear device instead of a learning device. That is rarely the sensor's fault. It happens because nobody told them: a single curve proves nothing. Only planned repetition turns numbers into insight.
You are sitting at the breakfast table. Your phone says 154. Yesterday, after the same bowl of muesli, it said 118. Same bowl, same spoon, same time of day. And now you sit there and wonder what you did wrong.
Probably nothing.
This is exactly the point where most people give up. Some put the sensor away because it is obviously measuring nonsense. Others cut out oats forever, because of one single number on one single morning. Both are understandable reactions to the same experience: the device delivers more data than it delivers context.
I would like to show you a third way. It takes 14 days, it is less comfortable than any app recommendation, and at the end there is something that genuinely belongs to you: your own pattern, in three to five sentences that you could defend against questions.
What is waiting for you here
- What the sensor under your skin actually measures, and how slow that is
- How large the measurement deviation is in healthy people, in numbers
- Why the same meal produces two different curves in two people
- What is normal in metabolically healthy people, with a real reference cohort
- The 14 day arc in four phases, visual and easy to follow
- How to test a lever so that the result actually means something
- Which spot on your curve says more than the peak does
- Where the counterposition stands, and when measuring tips into control
- Twelve questions that patients ask me about this
What is actually being measured under your skin
The device looks like a meter for blood. It is not one.
Under the round patch sits a wafer thin filament, a few millimetres deep in the fat tissue beneath your skin. There it does not swim in blood, it swims in the fluid that stands between your cells. An enzyme on the filament converts glucose, a tiny current is produced, and this current gets translated into a number. A measuring point every few minutes, and the software smooths what lies in between.
Picture a river, and beside it a quiet side arm. What happens in the river arrives in the side arm too. Just later, and a little blurred. Your sensor stands at the side arm.
A research group in Baltimore gave 14 people with type 1 diabetes two sensors at once in the abdomen and drew venous blood in parallel every five minutes over eight hours.
Tissue glucose lagged behind blood by 4 to 10 minutes, in 81 percent of cases. And the two sensors on the same person differed in timing by 6.7 minutes on average.
For you that means: your curve is a time shifted copy. Anyone who assigns the peak to one particular bite, down to the minute, often assigns it wrongly.
Boyne et al., Diabetes 2003 · [Case Series, n=14] · DOI: 10.2337/diabetes.52.11.2790The range you read in many guides is 5 to 15 minutes. That number comes from manufacturer information and secondary literature, not from this study. What is documented is 4 to 10 minutes. The difference sounds pedantic, but it is the core of this whole topic: many numbers circulate about sensors that nobody traces back to a source any more.
More important than the exact number of minutes is the second observation from the same work. Two sensors on the same abdomen, same person, same hour, and still a timing difference of almost seven minutes. If two parallel sensors do not run in sync, then your new sensor will not run in sync with the old one after a change either.
You are not measuring blood. You are measuring an echo of it, with a delay and with a character of its own per sensor.
That is not a weakness of the device that could be argued away. It is a property that shapes your interpretation. Comparisons within one sensor cycle are stable. Comparisons across a sensor change are less so.
In clinical practice I observe that many people see restless values on the first day with a new sensor and draw hasty conclusions from them. I have deliberately not cited systematic data on this in this article, because I did not find any solid data. What is documented is only that two sensors on the same person can differ in time. The rest is experience, and that is what I call it.
So the first rule is set before you have even eaten anything: you are working with a signal, not with a laboratory value. And now you can follow why the lag figure in your app is an approximation and not a stopwatch.
How accurate this is, and why you can still learn something
"I was at 160." I hear this sentence often in my consultations, and it sounds like a finding. It is not one. It is a sensor statement.
The difference is not hairsplitting, not since there has been clean data on it. The most interesting work comes from Bath in England and is only a few months old.
Fifteen healthy people completed seven laboratory visits in random order and received 50 grams of carbohydrate each time in a different form: pure glucose, whole fruit, pureed fruit, smoothies in various versions. The CGM ran in parallel with a fingertip blood sample every 15 minutes.
The sensor read around 0.9 mmol/l above the blood measurement both fasting and after eating, which is roughly 16 mg/dl. The same smoothie had a glycaemic index of 69 according to the sensor and 53 according to blood. The device overestimated time above 7.8 mmol/l by roughly fourfold, and even after correcting for the fasting offset still by roughly double. How large the deviation turned out to be differed from person to person.
For you that means: absolute values from the sensor are not a laboratory value. Comparing them with a threshold number from the internet compares apples with oranges.
Hutchins et al., Am J Clin Nutr 2025 · [RCT, n=15] · DOI: 10.1016/j.ajcnut.2025.02.024The field describes sensor accuracy with the abbreviation MARD, the mean absolute relative difference. It says by how many percent a sensor value deviates from the reference value on average. Many specific percentages circulate, almost always from manufacturer documents, and they get passed on unchecked. So I am not naming any here, and prefer the number from the randomised study above. It describes exactly the situation you are in: healthy, at home, with a meal in front of you.
You could write the sensor off because of this. In my view that would be too early. Because a systematic upward offset is largely irrelevant when you compare yourself with yourself. If your device lifts every value by the same amount, the difference between Monday and Wednesday still stands. What gets lost is the absolute number. What remains is the pattern.
A glucose sensor is a good pattern detector and a mediocre measuring instrument. Everything you do in the next 14 days should therefore aim at patterns and never at absolute values.
Stop asking: is 154 too high? Ask instead: is this course higher than my own course after the same meal the day before yesterday?
Your sensor cannot answer the first question. It can answer the second one very well. And only the second one leads to a decision you can check yourself.
Three rules follow from this, and they apply to the whole rest of this article. First: you compare only within the same sensor cycle. Second: you do not adopt anyone else's thresholds as a target. Third: at the start of every new sensor you note your morning fasting range, so that you know the level at which this device speaks. And now you can explain why two people with an identical meal and an identical metabolism could still post different numbers.
Why this is interesting at all in people without diabetes
Your friend eats the same bread roll as you. Her curve stays almost flat. Yours climbs steeply. You are sitting at the same table, you are eating the same thing, and your bodies are telling two different stories.
That is the finding the whole idea of self measurement rests on. And it is well documented.
An Israeli research group had 800 people wear a CGM for a week and recorded almost 47,000 meals along the way, plus blood values, body measurements, activity and the gut microbiome.
The response to identical meals differed considerably between participants. An algorithm that included personal data predicted the response markedly better than any general rule, and a diet adapted to it lowered post meal values in a blinded randomised arm.
For you that means: a general list of good and bad foods describes an average that exists in nobody exactly.
Zeevi et al., Cell 2015 · [Cohort, n=800] · DOI: 10.1016/j.cell.2015.11.001In the United Kingdom, 1,002 adults, many of them twin pairs, received standardised meals in the clinic and at home, accompanied by glucose, insulin and fat measurements as well as microbiome and genetics.
The coefficient of variation of the glucose response to identical meals was 68 percent. Genetic variants contributed only 9.5 percent to the prediction of the glucose response. For the fat response, person specific factors such as the microbiome explained more than the macronutrients of the meal itself.
For you that means: the spread is real and large. Your genes explain less of it than the advertising for gene tests suggests.
Berry et al., Nat Med 2020 · [Cohort, n=1,002] · DOI: 10.1038/s41591-020-0934-0At Stanford, 57 people with different metabolic status wore a CGM for two to four weeks, giving almost half a million measuring points in total.
People who counted as normoglycaemic by the usual criteria nevertheless spent around 15 percent of the time in a range that would be assigned to prediabetes if it were a fasting value. The patterns could be grouped into three types, from barely fluctuating to strongly fluctuating.
For you that means: fasting value and HbA1c describe averages, a sensor describes movement. Important here: this study collected no long term outcomes. A glucotype is a description of a pattern, not a risk class and not a prognosis.
Hall et al., PLoS Biol 2018 · [Cohort, n=57] · DOI: 10.1371/journal.pbio.2005143From the perspective of Clinical Psychoneuroimmunology this is no surprise. A meal never meets a neutral laboratory. It meets a system that is currently in a particular state. The microbiome can help decide how fast starch becomes sugar. The internal clock appears to help determine how willingly the beta cells answer. The sleep of the night before can change how sensitive muscle and liver are to insulin. And the stress axis can join in via cortisol, without asking you.
Nerves, immune system, metabolism and hormones are not separate chapters here. They are four voices in the same choir, and the curve on your phone is the sound that comes out.
The food alone does not decide your curve. The system that receives it decides along with it.
That is why "is rice good or bad" is the wrong question. The better one goes: under which conditions does my body answer rice mildly, and under which not?
One boundary, so you do not expect the wrong thing. If what mainly occupies you is the weight loss question, whether a sensor could change something about your weight, I have described that in detail elsewhere: in Blood sugar and weight loss: what a CGM sensor shows. This article is not about weight. It is about method, about how you arrive at a statement about yourself in the first place.
And now you can argue why you do not need a sensor to confirm tables, but to find out where you deviate from them.
What is normal in metabolically healthy people, in numbers
The most common expectation people have when they stick on a sensor is: flat. A line that barely moves, because surely that would be healthy.
The expectation is charming, and the reference data show something else.
At twelve centres, 153 healthy people without diabetes between 7 and 80 years of age wore a blinded sensor for up to ten days, so they could not see their own values.
Mean glucose across all age groups was 98 to 99 mg/dl. Median time between 70 and 140 mg/dl was 96 percent. The coefficient of variation within one person was 17 percent. And in the median, participants spent around 30 minutes a day above 140 mg/dl and around 15 minutes a day below 70 mg/dl.
For you that means: even in metabolically healthy people the curve is not flat. Half an hour a day above 140 and a quarter of an hour below 70 are part of everyday life in this reference group.
Shah et al., J Clin Endocrinol Metab 2019 · [Cohort, n=153] · DOI: 10.1210/jc.2018-02763And now the trap almost every app falls into. The metrics your program shows you, time in range, time above, time below and coefficient of variation, come from an international consensus paper from 2019. That paper was written for people with diabetes. The target ranges named there are treatment goals of a therapy, not normal values for healthy people. Anyone who applies them to themselves is borrowing a foreign yardstick.
A number from a treatment goal is not a target for a healthy person. The consensus paper on time in range describes what diabetes therapy works towards. Your 14 days describe how your body responds to everyday life.
That is why you will find no thresholds in this article that you are supposed to meet. You will find questions to put to your own data.
Two curves, the same number of calories
So that you know what we are talking about, here are two schematic courses. They are not measured, they are drawn, and they show exactly the two shapes that the next two weeks are about.
Mild course
slow rise, rounded peak, calm returnThe peak stays moderate, the return happens without an undershoot. After two hours you are back roughly where you started.
Steep course with a dip
fast rise, sharp peak, undershoot afterwardsThe peak is higher and narrower, and afterwards the curve falls below baseline. This dip is exactly the spot we still need to talk about in section 8.
Your curve is not a report card. It does not get a grade.
Ask your data instead of grading it: how high is my peak compared with my own peak after the same meal? How long does the return take? Does a dip follow? Is my night calm? Those are questions your sensor can answer. "Am I healthy" is not one of them.
And now you know why the expectation of "always flat" would lead to disappointment by the first breakfast at the latest, even though nothing has gone wrong.
Days 1 to 3: just look, change nothing
Now comes the part where most people lose patience. The sensor is on, the app shows numbers, and the reflex is overwhelming: drop the bread right now, cut the banana right now, do something differently right now.
Please do not. Not yet.
Before we go into the phases, here is the whole arc at a glance. Four phases, fourteen days, each phase with a single task.
Observe
- eat as always, change nothing
- note your fasting range in the morning
- record the night course and your sleeping side
- goal: an honest baseline
Same food, different conditions
- one food, several times of day
- with and without protein beforehand
- with and without movement afterwards
- goal: see the influence of circumstances
Test the levers
- order of foods on the plate
- a walk after eating
- vinegar with the meal
- short night versus normal night
Build your version
- bring the repetitions together
- formulate three to five sentences
- mark single observations as hypotheses
- goal: a version you can explain
This arc is structured self observation. It is not diagnostics, not a test and not a therapy. No study protocol has tested exactly these 14 days. What has been tested are the individual building blocks, and you will find each of them in this article with a source.
It therefore deliberately contains no target values you are supposed to reach and no instruction about what you should eat. If you suspect diabetes, or if your values worry you, that belongs in a medical work up with the established tests and not in an app.
Back to the first three days. They feel like lost time, and they are the opposite of that. Without a baseline you have nothing to compare against later. Every change you make on day 2 makes day 9 unreadable.
What you collect in this phase is four things. First, your morning range before breakfast, over three days, so that you know the level of this sensor. Second, your night course, along with a note on which side you slept. Third, your usual daily rhythm with the times of your meals. Fourth, your sleep duration, honestly noted, not estimated.
Phase 1: what you record
- Food and time. A photo is enough. The time of day matters more than the number of grams.
- Sleep. When to bed, when up. Mark short nights.
- Movement. Only yes or no and roughly when, no training logs.
- Sleeping side. Left, right or back. Sounds silly, explains night time outliers later.
- Special days. Ill, stressed, alcohol, cycle phase, travel.
A practical note for the start, without turning it into a demand: applying a sensor for the first time is sensibly done with medical guidance. Not because it is complicated, but because the first questions are usually not technical ones, they are questions of content. What you are measuring, why you are measuring it, and where the limits lie, becomes clear faster in a conversation than in an instruction leaflet.
The first three days are not a wasted start. They are the yardstick.
Anyone who changes something immediately ends up measuring their own excitement as well. Anyone who just looks for three days gets a baseline against which everything else can be checked. That is unspectacular, and it is half the work.
And now you can explain why a sensor worn for only three days often creates more confusion than clarity.
Days 4 to 7: the same food, different conditions
"Rice is bad for me. I have known that since Tuesday." I hear this sentence often, and it is usually premature.
Because before you can say anything about a food, you need to know how much your own response varies from day to day. There is a study on exactly that, and I consider it the most important one in this whole article.
In Boston, 23 healthy adults between 20 and 70 years of age ate the same commercial white bread over and over in up to three test rounds, 50 grams of available carbohydrate each time, in random order against pure glucose.
The glycaemic index of the same bread was 78 in the first round with a standard deviation of 15. Across the complete rounds the values came out as 78, then 60, then 75. In the analysis of variance, the variation between different people was 17.8 percent, while the variation within the same person was 42.8 percent.
For you that means: your own body answers the same bread more differently on different days than different people differ from each other. A single test therefore proves nothing.
Vega-López et al., Diabetes Care 2007 · [RCT, n=23] · DOI: 10.2337/dc06-1598This one number is the reason why this plan takes 14 days and not three. And it is the reason for the most important rule of the next phase: every test is done at least twice, better three times.
Why the same meal turns out differently on different days has several reasons. The best documented one is the time of day.
Twenty healthy volunteers with normal fasting values ate identical mixed meals on three consecutive days at 07:00, 13:00 and 19:00, in randomised order and with the same physical activity.
The glucose rise after breakfast was significantly smaller than after lunch and dinner. The readiness of the beta cells to respond was higher in the morning, as was the disposition index.
For you that means: the same meal in the evening is not the same meal. If you test rice in the morning and next time in the evening, you are comparing two different experiments.
Saad et al., Diabetes 2012 · [RCT, n=20] · DOI: 10.2337/db11-1478Fourteen young, slim and healthy women wore a CGM for five days and ate identical test meals at home, with dinner either at 21:00, at 18:00, or divided between both times.
The late dinner produced a higher peak than the early one, 2.74 versus 1.57 mmol/l, and a markedly larger area during the night between 23:00 and 08:00. The divided dinner sat in between and additionally lowered the range of fluctuation across the day.
For you that means: "the same food, three hours earlier" is a genuine test candidate, and one that has been studied in healthy people. The sample was small and the duration short.
Kajiyama et al., Diabetes Res Clin Pract 2018 · [RCT, n=14] · DOI: 10.1016/j.diabres.2017.11.033The second big influence is what lies in the stomach before the carbohydrates. The mechanism behind it is called gastric emptying and incretins, and it was made visible in a very small but very clean study: eight people with diet controlled type 2 diabetes drank a broth 30 minutes before a potato meal, once with 55 grams of whey protein, once without. With protein beforehand the stomach emptied most slowly, the glucose area was lower, and GLP-1 rose most strongly (Ma et al. 2009, [Case Series, n=8]).
A third variable worth trying: the degree of processing. Whole fruit versus puree versus smoothie was even part of the design in the accuracy study from section 2. Why texture and processing can make so much difference I have described more fully in Unprocessed food: why real food fills you up. For your phase 2 this is enough: the same fruit once as fruit, once as a smoothie, same amount, same time of day.
Phase 2: the four rules for every single test
- One variable. Per test you change exactly one thing. Everything else stays the same.
- Twice, better three times. One result is a hypothesis. Two are a hint.
- Same time of day. Otherwise you are measuring the internal clock instead of the food.
- Note the night. After a short night the test is not counted, it is repeated.
- Four quiet hours beforehand. What you ate before reaches into the test.
One test result is a hypothesis. Two are a hint. Three are a pattern.
That sounds like scientific bureaucracy and is in fact a kindness towards you. It can keep you from cutting a food out of your life because of one bad Tuesday.
And now you can argue why a statement about rice takes you four days and not four minutes.
Days 8 to 11: testing the levers
Now it gets interesting. Because now you finally get to change something.
Four days, four levers, each lever tested against itself. The principle comes straight from the studies that examined these levers: same meal, same time of day, at least one day apart, and exactly one changed condition. That is a crossover design in miniature, and you can rebuild it at home.
Before we start, one piece of honesty up front: almost all of these studies were done in people with type 2 diabetes, prediabetes or obesity. The percentages from them cannot simply be transferred to healthy people. That is exactly why you test them on yourself.
Lever 1: the order on the plate
At a New York clinic, eleven people with obesity and metformin treated type 2 diabetes ate exactly the same 628 calorie meal on two days one week apart, once with carbohydrates first, once with vegetables and protein first.
With vegetables and protein first, values at 30, 60 and 120 minutes were 28.6, 37.0 and 16.8 percent lower. The area under the curve over two hours was 73.5 percent lower, and insulin after one hour 49.6 percent lower.
For you that means: food order is a lever in its own right, independent of what is on the plate. But careful: eleven people, no randomised sequence, and a population with diabetes. The effect is large, the study is small.
Shukla et al., Diabetes Care 2015 · [Case Series, n=11] · DOI: 10.2337/dc15-0429The same group later repeated the experiment in randomised form in 15 people with prediabetes, with three orders and blood samples over three hours. Peaks were more than 40 percent lower with "carbohydrates last", the area 38.8 percent lower (Shukla et al. 2019, [RCT, n=15]). So the effect also shows up before the diabetes threshold. What it does in a metabolically healthy person is not answered by this, and that is your test for day 8.
Lever 2: movement after eating
An Irish research group pooled seven acute randomised crossover trials in which prolonged sitting was compared with short standing or walking breaks.
Standing breaks lowered glucose after meals with an effect size of Cohen's d equal to minus 0.31, light walking with minus 0.72, and for insulin with minus 0.83. In the direct comparison, walking did better than standing.
For you that means: in these studies getting up did better than staying seated, and walking did better than standing. Whether that becomes visible in you is something you can check. Participants were mostly living with obesity, and each study lasted only one day.
Buffey et al., Sports Med 2022 · [Meta-analysis, k=7] · DOI: 10.1007/s40279-022-01649-4Two details are worth having in your test plan. First: the timing counts more than the total duration. In ten older people with elevated fasting values, three times 15 minutes of walking after meals beat 45 minutes of walking in one block in the hours after dinner (DiPietro et al. 2013, [RCT, n=10]). Second: in 41 people with type 2 diabetes, ten minutes of walking after each main meal lowered the area under the curve more than the same walking time at some point in the day, with the largest difference after dinner (Reynolds et al. 2016, [RCT, n=41]).
In people without diabetes the effect turns out markedly smaller. A meta-analysis of 23 studies with 408 participants without diabetes found a mean glucose reduction of 0.17 mmol/l for exercise, a reduction of the peak value by 0.63 mmol/l and 6.22 percentage points more time in range. The authors explicitly call these effects small and call for larger studies.
So walking after a meal can change a number. Whether an illness can be prevented with it is not something this work says.
Lever 3: vinegar with the meal
The cheapest test candidate in the whole plan. A systematic review with meta-analysis found a standardised mean difference of minus 0.60 for the glucose area and minus 1.30 for the insulin area with vinegar taken with a meal (Shishehbor et al. 2017, [Systematic Review]). The confidence interval for glucose did however reach close to zero.
In twelve healthy volunteers a clear dose response relationship appeared: the more acetic acid added to the white bread, the lower glucose and insulin after 15 to 45 minutes, and the higher the reported satiety (Östman et al. 2005, [RCT, n=12]). They worked with 18 to 28 millimoles of acetic acid to 50 grams of carbohydrate. I deliberately do not convert that into tablespoons here, because an everyday dose does not follow directly from it. In any case I find the second finding more interesting: satiety rose along with it. Perhaps that is the more exciting part.
Lever 4: the night before
In Leiden, nine healthy people were studied twice, once after a normal night from 23:00 to 07:30, once after only four hours of sleep, each time with polysomnography and a clamp study to measure insulin sensitivity.
Fasting values did not change. Under the clamp study, however, the body's own glucose production rose, glucose uptake fell, and the required glucose infusion rate was around 25 percent lower.
For you that means: a single short night can measurably change the next day's response. Anyone who does not note it ascribes to food what belongs to the night.
Donga et al., J Clin Endocrinol Metab 2010 · [Case Series, n=9] · DOI: 10.1210/jc.2009-2430The classic on this is older: eleven young men spent six nights with only four hours in bed and afterwards showed poorer glucose tolerance, raised evening cortisol and increased sympathetic activity (Spiegel et al. 1999, [Case Series, n=11]). Small, male, young and under extreme conditions. Much closer to everyday life is an analysis from PREDICT: in 953 healthy adults with more than 8,000 standardised meals, sleep efficiency and sleep timing were linked to the glucose response to breakfast the next morning, also within the same person (Tsereteli et al. 2022, [Cohort, n=953]). Notable about it: it was not only less sleep that counted, but also sleep that was different from usual.
That leaves stress. And here I have to pull the brake. What is documented is that cortisol given as a night time infusion in eight healthy people lowered glucose effectiveness and raised glucose as well as free fatty acids, despite higher insulin (Nielsen et al. 2004, [Case Series, n=8]). That was an infusion, not a meeting. That your argument on the phone or your deadline lifts the curve is mechanistically plausible and I observe it often in clinical practice. As a human study with an everyday stressor I cannot document it for you here. That is exactly how you should read it.
Phase 3: how to test a lever cleanly
- The same meal, same amount, same time of day, on two days.
- Day A without the lever, day B with the lever. Nothing else changes.
- At least one day apart, so the meal before does not reach into it.
- Note the sleep of both nights. After a short night you postpone.
- Look at both curves side by side, not only at the peak number.
- Repeat when the difference is small. Small differences are often noise.
One note on scope: the levers themselves, meaning order, combination and timing without a sensor, I have described in detail in Avoiding glucose spikes: order, combination, timing. That article says which levers exist. This one says how you check whether they show up in you at all. That is a difference that matters to me: not "eat vegetables first", but "this is how you check on yourself whether the effect from these studies becomes visible in you".
You are not testing the food. You are testing yourself.
The studies have already answered the question of whether a lever can change something on average. Your question is a different and far more personal one: does it change enough in you to be worth the effort? Some of these levers will look large in you, others not at all. Both are good results.
And now you can explain why a lever that works for your colleague might still change almost nothing in you, without either of you doing anything wrong.
Days 12 to 14: what the curve says, and what it does not say
In the end you want to know: was that good or bad? And that is exactly the question the sensor does not ask. It shows a shape. You have to add the meaning, and there are five places you can orient yourself by.
| Place on the curve | What you can read there | The question to put to your data |
|---|---|---|
| Height of the peak | how strong the rise turns out | Higher or lower than in me after the same meal? |
| Time until return | how fast the system settles again | Am I back in my usual range after two hours? |
| The dip afterwards | undershoot 2 to 3 hours later | Am I hungry or unfocused afterwards? |
| Fasting range | the level you start from | Is my morning value stable across the 14 days? |
| Night course | calm or swings during sleep | Does a drop match the side I slept on? |
The third row is the one hardly anyone knows, and it is the most interesting.
In a British and an American cohort, 1,070 people ate 8,624 standardised and then more than 71,000 freely chosen meals, with CGM throughout, and reported hunger and calorie intake alongside.
The glucose dip two to three hours after the meal predicted hunger and later calorie intake better than the peak or the area under the curve. The associations were however weak to moderate, with correlations between 0.14 and 0.27.
For you that means: the most interesting place on your curve is not the peak, it is the valley afterwards. It explains part of your hunger, not all of it.
Wyatt et al., Nat Metab 2021 · [Cohort, n=1,070] · DOI: 10.1038/s42255-021-00383-xBefore you turn a night time drop into a diagnosis, check the technology. In a very small study of four healthy men, each wearing four sensors at once on the abdomen, individual sensors dropped by around 40 mg/dl over 30 to 60 minutes, precisely when the person was lying on that sensor (Mensh et al. 2013, [Case Series, n=4]). A modelling study in 72 sensor wearers puts such compression artefacts at a median of 45 minutes and 24 mg/dl, more frequent at night than during the day (Facchinetti et al. 2016, [Cohort, n=72]).
A night time drop to 55 without symptoms, which disappears again after 40 minutes and occurs on the side you slept on, is first of all a suspicion of pressure. It is not a reason to cut carbohydrates in the evening.
The counterposition, and why it belongs in this article
Three papers that argue against the sensor
First. A meta-analysis of 25 randomised trials with 2,996 adults examined CGM as a tool for behaviour change. Result: HbA1c 0.28 percentage points lower, time in range 7.4 percentage points higher, but no significant effect on BMI or weight. Eleven of the 25 studies declared conflicts of interest with sensor manufacturers, and 17 ran in type 2 diabetes (Richardson et al. 2024, [Meta-analysis, k=25, n=2,996]).
Second. A review in a diabetology journal examined the commercial promise of benefit for people without diabetes in three steps: does the device detect abnormalities, does it change behaviour, does it improve metabolic health? For none of the three steps did the authors find consistent, high quality evidence. They call the advertising claims misleading (Oganesova et al. 2024, [Review]).
Third. A systematic review on the question of whether CGM could guide cardiovascular prevention in healthy people concludes that the data are thin and the effect on hard endpoints unclear (Wilczek et al. 2025, [Systematic Review]).
I do not consider these three papers a reason to put the sensor away. I consider them the reason to use it properly: as a learning tool for your behaviour, not as proof of health.
Part of this is also the most famous work behind the sentence "swings do more harm than height". In a French study, 21 people with type 2 diabetes were compared with 21 healthy controls. Only the amplitude of fluctuation and the area after meals correlated with a marker of oxidative stress in urine, but not HbA1c or fasting value (Monnier et al. 2006, [Cohort, n=21]). That is a small case control study in people with diabetes, measuring a laboratory value and not a heart attack. It cannot be transferred to metabolically healthy people, however often it is cited for that purpose.
A single metric rarely says as much as it appears to say. That is true for the calorie count on the package, as I described in The calorie myth: why "eat half of it" is rarely enough, and it is true for cholesterol, as you can read in Cholesterol and science. The glucose peak joins this family: an interesting signal that is easily over interpreted without context.
Phase 4: your version in three to five sentences
- Only what you have seen at least twice may stand as a sentence.
- Everything one off gets marked as a hypothesis and checked with the next sensor.
- Every sentence names the condition, not only the food. So not "rice does not work", but "rice in the evening without salad beforehand looks different in me than at lunchtime with it".
- One sentence on the night, one on movement, one on the time of day.
- What you make of it is decided by your everyday life, not by your sensor.
A flatter curve is an intermediate result, not proof of health.
Between "my curve has become calmer" and "my heart is healthier" lies a gap that nobody has filled so far. That should not discourage you. It should keep you from turning a number on your phone into a life plan.
If you would rather not interpret your 14 days alone: below this article you will find the option to book an appointment.
And now you can say which place on your curve actually tells you something about your everyday life, and which one you are allowed to leave in peace.
When measuring becomes control, and who this is not for
There is a moment when the device takes the lead. It announces itself quietly. You are sitting at dinner with friends and looking at your phone. You no longer order what you feel like, you order what made a nice curve yesterday. You feel relieved when the number stays low, and guilty when it rises.
That is the point where a learning device tips over.
I want to be honest here about what is documented. There is no frequency figure for how often people without diabetes develop disordered eating through self measurement. What does exist is a professional warning: the review from 2024 mentioned earlier explicitly names the lack of data on unfavourable effects on eating behaviour as one of the biggest open gaps in use by people without diabetes. A research gap is not proof of danger. But it is not an all clear either.
When you choose meals only by the number you expect. When your list of allowed foods gets shorter from week to week. When you cancel invitations because you cannot control things there. When you are afraid before eating. When a high curve leaves you wanting to make up for something.
Anyone with a history of an eating disorder should not do this plan without medical support. Why body and psyche are so closely linked around eating I have described in Understanding eating disorders: body and psyche.
Taking the sensor off in such a moment is not failure. It is a good decision, and one that your body is suggesting to you. In my consultations I hear this story regularly, and relief almost always follows once the device is gone.
Who these 14 days might be worthwhile for
More likely useful
- You have a concrete question, for example why your afternoon always collapses.
- You like data and are not thrown off by single outliers.
- You want to check levers on yourself instead of following general lists.
- You have an irregular everyday life, shift work or a lot of travel.
- There is type 2 diabetes in your family and you want to develop a feel for it early.
- You feel like doing something systematically for 14 days.
More likely not
- You have a history of an eating disorder or tend towards control around food.
- You expect the sensor to do the work of losing weight for you.
- You are looking for a diagnosis. There are established tests for that, and the sensor is not among them.
- You are in a very demanding phase of life right now.
- You only want to glance at the data once. Three days will give you little.
- You tend to turn every number into a rule immediately.
And if your curve worries you? Then the next step is not a second sensor. The diagnosis of diabetes and prediabetes rests, according to the 2025 Standards of Care of the American Diabetes Association, on HbA1c, fasting plasma glucose and the oral glucose tolerance test. A tissue sensor is not a diagnostic criterion there (ADA 2025, [Guideline Document]). The sensor may ask you a question. It does not give the answer.
A glucose sensor does not answer a question. It asks one. And the answer only comes into being through the way you handle it over fourteen days.
The goal of these two weeks is not a lower number. The goal is a better feel for your own body, supported by data.
If at the end you can say three sentences about yourself that nobody knew before, it was a success. Even if your curves look exactly the same as on the first day.
And now you know why the most honest answer to the question "should I stick one of those things on" begins with a counter question: what exactly do you want to find out?
Common questions about glucose sensors without diabetes
Is a glucose sensor worth it if I do not have diabetes?
That depends on what you expect from it. As a learning device a sensor can show you a great deal, because the glucose response to identical meals varies widely between people. In the PREDICT 1 cohort of 1,002 adults the coefficient of variation of the glucose response was 68 percent. As proof of health it does not work: a systematic review from 2024 found neither reliable reference values for people without diabetes nor solid evidence that measuring improves metabolic health. If you test in a structured way for 14 days and can then say three to five sentences about yourself, you have gained a lot. If you expect low numbers, you will more likely be disappointed.
How high may blood sugar rise after a meal in a healthy person?
First the framing: your sensor does not measure blood sugar, it measures glucose in the fluid between your cells. In the cleanest reference study so far, in 153 metabolically healthy people, mean glucose was 98 to 99 mg/dl, time between 70 and 140 mg/dl was 96 percent, and participants spent a median of around 30 minutes a day above 140 mg/dl and around 15 minutes below 70 mg/dl. A flat curve is therefore not the norm, it is the exception. Instead of looking for an upper limit, the more useful question is: how often and how long do you sit above your own usual range?
How accurate is a CGM sensor really?
More accurate than its reputation when it comes to patterns, less accurate than its reputation when it comes to the number. In a randomised crossover trial with 15 healthy people the CGM read on average 0.9 mmol/l higher than capillary glucose measured in parallel, both fasting and after meals. The same smoothie had a glycaemic index of 69 according to the sensor and 53 according to the blood measurement. The sensor overestimated time above 7.8 mmol/l by roughly fourfold. How large the deviation was differed from person to person. For comparisons with yourself within one sensor cycle the device is well suited, for absolute values it is not.
Why does my sensor suddenly show very low values at night?
Very often that is a pressure signal and not a metabolic signal. In a very small study of four healthy men, each wearing four sensors at the same time, individual sensors dropped by around 40 mg/dl over 30 to 60 minutes, precisely when the person was lying on that particular sensor. A modelling study in 72 sensor wearers puts such compression artefacts at a median of 45 minutes duration and 24 mg/dl amplitude, more frequent at night than during the day. So note which side you slept on. A night time dip without symptoms is first of all a suspicion of pressure.
Why is my curve different on two days after the same meal?
Because that is normal. In a study of 23 healthy adults who repeatedly ate the same commercial white bread, the variation within one person, with a coefficient of variation of 42.8 percent, was larger than the variation between different people at 17.8 percent. Your body answers the same bread more differently on different days than different people differ from each other. Time of day, the sleep of the night before, movement, stress and the meal before all play along. That is exactly why a single curve proves nothing and why every test belongs done at least twice.
How long do I have to wear a sensor before I can learn something from it?
For a feeling, three days are enough. For a statement, they are not. Because the variation within one person is large, you need repetitions, and repetitions need days. Two weeks are a workable frame: three days of pure observation, four days of the same food under different conditions, four days of testing single levers, three days of pulling it together and building your own version. This plan as a whole has not been tested in any study. Its individual building blocks have. It is structured self observation, not a test and not diagnostics.
Can a glucose sensor detect diabetes?
No, and that matters. The diagnosis of diabetes and prediabetes rests, according to the 2025 Standards of Care of the American Diabetes Association, on HbA1c, fasting plasma glucose and the oral glucose tolerance test. A tissue sensor is not a diagnostic criterion there. It can ask you a question, it does not give the answer. If your curve worries you, if values stay persistently high, if you notice thirst, frequent urination, weight loss or vision problems, that belongs in medical hands and not in a second sensor.
What does the lag between tissue and blood mean for my interpretation?
It means your curve is a time shifted copy. In a study of 14 people wearing two sensors each, the time difference between venous blood and interstitial fluid was between 4 and 10 minutes, and in 81 percent of cases the tissue glucose lagged behind. Two sensors on the same person differed in timing by 6.7 minutes on average. In practice: do not assign the peak to one particular bite, compare curves only within the same sensor, and treat a sensor change as a break in the time axis.
Does a walk after eating really make a measurable difference?
In studies yes, in varying size. A meta-analysis of seven acute crossover trials found an effect of Cohen's d equal to minus 0.72 on glucose after meals for light walking compared with uninterrupted sitting. In 41 people with type 2 diabetes, walking directly after meals lowered the area under the curve more than the same walking time in one block, most clearly after dinner. In people without diabetes it turns out smaller: a meta-analysis of 23 studies with 408 participants found a mean glucose reduction of 0.17 mmol/l. Whether it becomes visible in you is something you only see once you test it twice against twice.
Can the order of foods change my curve?
The effect is documented above all in people with type 2 diabetes and with prediabetes. In a pilot study with 11 people with obesity and type 2 diabetes, the area under the glucose curve was 73.5 percent lower when vegetables and protein were eaten 15 minutes before the carbohydrates. In a randomised study with 15 people with prediabetes the peaks were more than 40 percent lower. The mechanism behind it is slower gastric emptying and a different incretin response. For metabolically healthy people these percentages cannot simply be transferred. That is exactly why food order is a good test candidate for day 8.
Does constant measuring create fear of food?
It can. Solid numbers on this are missing, and that is precisely the point: a review from 2024 names the lack of data on unfavourable effects on eating behaviour as one of the biggest open gaps in use by people without diabetes. Warning signs are choosing meals only by the expected number, cancelling invitations, a food list that keeps getting shorter, or looking at your phone while you eat. Anyone with a history of an eating disorder should not do this plan without medical support. If signs of compulsive control appear, taking the sensor off is not failure, it is a good decision.
What do I do with my data once the 14 days are over?
You write three to five sentences that you could defend against questions. For example: my breakfast turns out milder than the same food in the evening, a ten minute walk visibly changes the course in me, after a short night my morning looks different. Anything you have seen only once stays a hypothesis. After that you do not need the sensor for a while, because what changes now is behaviour, not measurement. And anything that looks like illness belongs in a medical work up with the established tests.
The glucose sensor in a wider context
A glucose curve is never only a glucose curve. It hangs on the insulin sensitivity of your muscles, on hormones, on your training history and on the question of how your brain reads fullness. Several paths lead onward from here.
Insulin resistance
What can sit behind stubborn curves and stubborn kilos
Leptin and insulin
The two hormones regulating in the background
Zone 2 training
Why calm endurance work shapes the metabolism too
Hormones in women
Why your cycle can help shape your curves
Scientific sources
- Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52(11):2790-4. DOI: 10.2337/diabetes.52.11.2790 · PMID: 14578298 [Case Series, n=14]
- Hutchins KM, Betts JA, Thompson D, Hengist A, Gonzalez JT. Continuous glucose monitor overestimates glycemia, with the magnitude of bias varying by postprandial test and individual: a randomized crossover trial. Am J Clin Nutr. 2025;121(5):1025-34. DOI: 10.1016/j.ajcnut.2025.02.024 · PMID: 40021059 [RCT, n=15]
- Mensh BD, Wisniewski NA, Neil BM, Burnett DR. Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol. 2013;7(4):863-70. DOI: 10.1177/193229681300700408 · PMID: 23911167 [Case Series, n=4]
- Facchinetti A, Del Favero S, Sparacino G, Cobelli C. Modeling transient disconnections and compression artifacts of continuous glucose sensors. Diabetes Technol Ther. 2016;18(4):264-72. DOI: 10.1089/dia.2015.0250 · PMID: 26882463 [Cohort, n=72]
- Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-603. DOI: 10.2337/dci19-0028 · PMID: 31177185 [Review]
- Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079-94. DOI: 10.1016/j.cell.2015.11.001 · PMID: 26590418 [Cohort, n=800]
- Berry SE, Valdes AM, Drew DA, et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26(6):964-73. DOI: 10.1038/s41591-020-0934-0 · PMID: 32528151 [Cohort, n=1,002]
- Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 2018;16(7):e2005143. DOI: 10.1371/journal.pbio.2005143 · PMID: 30040822 [Cohort, n=57]
- Vega-López S, Ausman LM, Griffith JL, Lichtenstein AH. Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care. 2007;30(6):1412-7. DOI: 10.2337/dc06-1598 · PMID: 17384339 [RCT, n=23]
- Shah VN, DuBose SN, Li Z, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab. 2019;104(10):4356-64. DOI: 10.1210/jc.2018-02763 · PMID: 31127824 [Cohort, n=153]
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2025. Diabetes Care. 2025;48(Suppl 1):S27-S49. DOI: 10.2337/dc25-S002 · PMID: 39651986 [Guideline Document]
- Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care. 2015;38(7):e98-e99. DOI: 10.2337/dc15-0429 · PMID: 26106234 [Case Series, n=11]
- Shukla AP, Dickison M, Coughlin N, et al. The impact of food order on postprandial glycaemic excursions in prediabetes. Diabetes Obes Metab. 2019;21(2):377-81. DOI: 10.1111/dom.13503 · PMID: 30101510 [RCT, n=15]
- Buffey AJ, Herring MP, Langley CK, Donnelly AE, Carson BP. The acute effects of interrupting prolonged sitting time in adults with standing and light-intensity walking on biomarkers of cardiometabolic health in adults: a systematic review and meta-analysis. Sports Med. 2022;52(8):1765-87. DOI: 10.1007/s40279-022-01649-4 · PMID: 35147898 [Meta-analysis, k=7]
- DiPietro L, Gribok A, Stevens MS, Hamm LF, Rumpler W. Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care. 2013;36(10):3262-8. DOI: 10.2337/dc13-0084 · PMID: 23761134 [RCT, n=10]
- Reynolds AN, Mann JI, Williams S, Venn BJ. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia. 2016;59(12):2572-8. DOI: 10.1007/s00125-016-4085-2 · PMID: 27747394 [RCT, n=41]
- Yang B, Sun F, Poon ET, Wang J, Zhang X. Effects of exercise interventions on 24-h continuous glucose profiles in non-diabetic populations: a systematic review and meta-analysis. Diabetes Obes Metab. 2026;28(3):1854-66. DOI: 10.1111/dom.70368 · PMID: 41417544 [Meta-analysis, k=23, n=408]
- Shishehbor F, Mansoori A, Shirani F. Vinegar consumption can attenuate postprandial glucose and insulin responses: a systematic review and meta-analysis of clinical trials. Diabetes Res Clin Pract. 2017;127:1-9. DOI: 10.1016/j.diabres.2017.01.021 · PMID: 28292654 [Systematic Review]
- Östman E, Granfeldt Y, Persson L, Björck I. Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. Eur J Clin Nutr. 2005;59(9):983-8. DOI: 10.1038/sj.ejcn.1602197 · PMID: 16015276 [RCT, n=12]
- Ma J, Stevens JE, Cukier K, et al. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care. 2009;32(9):1600-2. DOI: 10.2337/dc09-0723 · PMID: 19542012 [Case Series, n=8]
- Saad A, Dalla Man C, Nandy DK, et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012;61(11):2691-700. DOI: 10.2337/db11-1478 · PMID: 22751690 [RCT, n=20]
- Kajiyama S, Imai S, Hashimoto Y, et al. Divided consumption of late-night-dinner improves glucose excursions in young healthy women: a randomized cross-over clinical trial. Diabetes Res Clin Pract. 2018;136:78-84. DOI: 10.1016/j.diabres.2017.11.033 · PMID: 29199002 [RCT, n=14]
- Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-9. DOI: 10.1016/S0140-6736(99)01376-8 · PMID: 10543671 [Case Series, n=11]
- Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab. 2010;95(6):2963-8. DOI: 10.1210/jc.2009-2430 · PMID: 20371664 [Case Series, n=9]
- Tsereteli N, Vallat R, Fernandez-Tajes J, et al. Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions. Diabetologia. 2022;65(2):356-65. DOI: 10.1007/s00125-021-05608-y · PMID: 34845532 [Cohort, n=953]
- Nielsen MF, Caumo A, Chandramouli V, et al. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects. Am J Physiol Endocrinol Metab. 2004;286(1):E102-10. DOI: 10.1152/ajpendo.00566.2002 · PMID: 12965873 [Case Series, n=8]
- Wyatt P, Berry SE, Finlayson G, et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat Metab. 2021;3(4):523-9. DOI: 10.1038/s42255-021-00383-x · PMID: 33846643 [Cohort, n=1,070]
- Richardson KM, Jospe MR, Bohlen LC, et al. The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. Int J Behav Nutr Phys Act. 2024;21(1):145. DOI: 10.1186/s12966-024-01692-6 · PMID: 39716288 [Meta-analysis, k=25, n=2,996]
- Oganesova Z, Pemberton J, Brown A. Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: a narrative review. Diabet Med. 2024;41(9):e15369. DOI: 10.1111/dme.15369 · PMID: 38925143 [Review]
- Wilczek F, van der Stouwe JG, Petrasch G, Niederseer D. Non-invasive continuous glucose monitoring in patients without diabetes: use in cardiovascular prevention, a systematic review. Sensors (Basel). 2025;25(1):187. DOI: 10.3390/s25010187 · PMID: 39796978 [Systematic Review]
- Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7. DOI: 10.1001/jama.295.14.1681 · PMID: 16609090 [Cohort, n=21]